Yahoo Finance New Strong Buy Stocks For April 20th
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Aerpio Pharmaceuticals, Inc. (ARPO): This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 12.2% over the last 60 days.
Aerpio Pharmaceuticals, Inc. Price and Consensus
Aerpio Pharmaceuticals, Inc. price-consensus-chart | Aerpio Pharmaceuticals, Inc. Quote
The Ensign Group, Inc. (ENSG): This company that provides health care services has seen the Zacks Consensus Estimate for its current year earnings increasing 3.2% over the last 60 days.
The Ensign Group, Inc. Price and Consensus
The Ensign Group, Inc. price-consensus-chart | The Ensign Group, Inc. Quote
Exterran Corporation (EXTN): This company that is involved in compression, production and processing products and services of the oil and natural gas industry has seen the Zacks Consensus Estimate for its current year earnings increasing 45.8% over the last 60 days.
Exterran Corporation Price and Consensus
Exterran Corporation price-consensus-chart | Exterran Corporation Quote
Huntington Ingalls Industries, Inc. (HII): This company that designs, builds and maintains nuclear-powered ships such as aircraft carriers and submarines, and non-nuclear ships has seen the Zacks Consensus Estimate for its current year earnings increasing 0.9% over the last 60 days.
Huntington Ingalls Industries, Inc. Price and Consensus
Huntington Ingalls Industries, Inc. price-consensus-chart | Huntington Ingalls Industries, Inc. Quote
SLM Corporation (SLM): This company that is a bellwether in education finance in the U.S. has seen the Zacks Consensus Estimate for its current year earnings increasing 38.2% over the last 90 days.
SLM Corporation Price and Consensus
SLM Corporation price-consensus-chart | SLM Corporation Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
SLM Corporation (SLM) : Free Stock Analysis Report
Huntington Ingalls Industries, Inc. (HII) : Free Stock Analysis Report
Exterran Corporation (EXTN) : Free Stock Analysis Report
The Ensign Group, Inc. (ENSG) : Free Stock Analysis Report
Aerpio Pharmaceuticals, Inc. (ARPO) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
